117 related articles for article (PubMed ID: 30616317)
1. [Analysis of prognostic factors on multidisciplinary team for diagnosis, treatment and prevention of hepatocellular carcinoma].
Wang KY; Yang ZJ; Yu WX; Liu L; Chen Z; Guo YB
Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):829-834. PubMed ID: 30616317
[No Abstract] [Full Text] [Related]
2. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
[TBL] [Abstract][Full Text] [Related]
3. Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality.
Serper M; Taddei TH; Mehta R; D'Addeo K; Dai F; Aytaman A; Baytarian M; Fox R; Hunt K; Goldberg DS; Valderrama A; Kaplan DE;
Gastroenterology; 2017 Jun; 152(8):1954-1964. PubMed ID: 28283421
[TBL] [Abstract][Full Text] [Related]
4. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
[TBL] [Abstract][Full Text] [Related]
5. Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients.
Sinn DH; Choi GS; Park HC; Kim JM; Kim H; Song KD; Kang TW; Lee MW; Rhim H; Hyun D; Cho SK; Shin SW; Jeong WK; Kim SH; Yu JI; Ha SY; Lee SJ; Lim HY; Kim K; Ahn JH; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Joh JW; Lim HK; Paik SW
PLoS One; 2019; 14(1):e0210730. PubMed ID: 30640924
[TBL] [Abstract][Full Text] [Related]
6. Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib.
Howell J; Pinato DJ; Ramaswami R; Arizumi T; Ferrari C; Gibbin A; Burlone ME; Guaschino G; Toniutto P; Black J; Sellers L; Kudo M; Pirisi M; Sharma R
Oncotarget; 2017 May; 8(22):36161-36170. PubMed ID: 28212535
[TBL] [Abstract][Full Text] [Related]
7. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
[TBL] [Abstract][Full Text] [Related]
8. Better prognosis of hepatic resection combined with antiviral therapy for HBV-related hepatocellular carcinoma with BCLC Stage B/C.
Wei Q; Tian H; Luo HX; Zhang YC; Deng YN; Yao J; Li H; Chen GH; Yang Y
Asian J Surg; 2017 Nov; 40(6):453-462. PubMed ID: 27321176
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of patients with hepatocellular carcinoma are determined in multidisciplinary team meetings.
Charriere B; Muscari F; Maulat C; Bournet B; Bonnet D; Bureau C; Otal P; Peron JM; Suc B
J Surg Oncol; 2017 Mar; 115(3):330-336. PubMed ID: 27813094
[TBL] [Abstract][Full Text] [Related]
10. Treatment algorithm based on the multivariate survival analyses in patients with advanced hepatocellular carcinoma treated with trans-arterial chemoembolization.
Prajapati HJ; Kim HS
PLoS One; 2017; 12(2):e0170750. PubMed ID: 28170405
[TBL] [Abstract][Full Text] [Related]
11. Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma.
Yu Y; Lang QB; Chen Z; Li B; Yu CQ; Zhu DZ; Huang XQ; Zhai XF; Ling CQ
Chin Med J (Engl); 2009 Sep; 122(17):1990-5. PubMed ID: 19781383
[TBL] [Abstract][Full Text] [Related]
12. Duration of stable disease is associated with overall survival in patients with advanced hepatocellular carcinoma treated with sorafenib.
Arizumi T; Ueshima K; Chishina H; Kono M; Takita M; Kitai S; Inoue T; Yada N; Hagiwara S; Minami Y; Sakurai T; Nishida N; Kudo M
Dig Dis; 2014; 32(6):705-10. PubMed ID: 25376287
[TBL] [Abstract][Full Text] [Related]
13. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
14. Comparison of survival, safety, and efficacy after transarterial chemoembolization and radioembolization of Barcelona Clinic Liver Cancer stage B-C hepatocellular cancer patients.
Soydal C; Arslan MF; Kucuk ON; Idilman R; Bilgic S
Nucl Med Commun; 2016 Jun; 37(6):646-9. PubMed ID: 26905317
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapy.
Shao YY; Wu CH; Lu LC; Chan SY; Ma YY; Yen FC; Hsu CH; Cheng AL
J Hepatol; 2014 Feb; 60(2):313-8. PubMed ID: 24036008
[TBL] [Abstract][Full Text] [Related]
16. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.
Sapisochin G; Goldaracena N; Astete S; Laurence JM; Davidson D; Rafael E; Castells L; Sandroussi C; Bilbao I; Dopazo C; Grant DR; Lázaro JL; Caralt M; Ghanekar A; McGilvray ID; Lilly L; Cattral MS; Selzner M; Charco R; Greig PD
Ann Surg Oncol; 2015 Jul; 22(7):2286-94. PubMed ID: 25472651
[TBL] [Abstract][Full Text] [Related]
17. Antiviral therapy in the improvement of survival of patients with hepatitis B virus-related hepatocellular carcinoma treated with sorafenib.
Xu L; Gao H; Huang J; Wang H; Zhou Z; Zhang Y; Li S; Chen M
J Gastroenterol Hepatol; 2015 Jun; 30(6):1032-9. PubMed ID: 25639513
[TBL] [Abstract][Full Text] [Related]
18. [Pancreas multidisciplinary team optimizes the diagnosis and treatment of pancreas-related diseases and improves the prognosis of pancreatic cancer patients].
Li JA; Xu YL; Ding N; Ji Y; Liu LX; Rao SX; Zhang YQ; Yao XZ; Fan Y; Huang C; Zhou YH; Wu LL; Dong Y; Zhang L; Rong YF; Kuang TT; Xu XF; Liu L; Wang DS; Jin DY; Lou WH; Wu WC
Zhonghua Wai Ke Za Zhi; 2022 Jul; 60(7):666-673. PubMed ID: 35775259
[No Abstract] [Full Text] [Related]
19. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
[TBL] [Abstract][Full Text] [Related]
20. Jie-du granule preparation for the treatment of advanced hepatocellular carcinoma: a retrospective cohort study of 177 patients.
Chen LY; Zhai XF; Chen Z; Zhu JF; Qian PA; Zhao HT; Ling CQ
Oncotarget; 2017 May; 8(18):30471-30476. PubMed ID: 27791987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]